Biotechnology News

RESULTAT DU 1ER SEMESTRE 2026 Chiffre d’affaires en croissance de 4,5% à 84,5 M€ les produits propriétaires atteignent 37% du CAla part du CA hors France est de 46% Flux de trésorerie disponible de 4...

RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2026 Revenue up 4.5% to 84.5 M€ Proprietary products account for 37% of revenue46% of revenue generated outside France Free cash flow of €4 million after...

Easy Environmental Solutions Participates in International Roundtable at United Nations Headquarters During Climate Week NYC

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced its first initiative to bring an infrastructure team from another...

Celularity closes $10 million financing in an up to $28 million recapitalization, advancing growth and targeting positive operating cash flow by Q1 2027.

New XWRAP® research shows 74% higher histology resolution score vs. conventionally processed placental tissue.

MIRAMAR, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion...

2026 R&D Day presentation highlights include: Review of final Randomized Phase 2 overall survival results Supportive Preliminary MRD Study Data and translational findings Pathway to confirmatory...

New findings highlight the therapy’s ability to preferentially destroy MGMT-positive tumor cells, the specific population that survives standard treatments and drives disease recurrence. TAIPEI,...

SAN FRANCISCO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Claris Biotherapeutics, Inc., a late-stage biopharmaceutical company dedicated to advancing transformative therapies for sight-threatening...